Home » Topics » Regulatory » Patents

Patents
RSS

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

Sankyo describes anti-HIV agents

Nov. 8, 1996

HIV protease-inhibitory tetronic acids from P&U

Nov. 8, 1996

Hybridon files new patent for antisense oligonucleotides

Nov. 8, 1996

Sankyo discloses natural antibacterial compounds

Nov. 8, 1996

New penems from Suntory

Nov. 8, 1996

Lilly reports 5-HT1F agonists for migraine

Nov. 8, 1996

Novel tachykinin antagonists from Glaxo Wellcome

Nov. 8, 1996

NK1 antagonists described by Merck & Co.

Nov. 8, 1996

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...